Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Egalet
Egalet
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
Fierce Pharma
Mon, 02/18/19 - 07:34 pm
drug pricing
Egalet
Iroko Pharmaceuticals
Zorvolex
Egalet’s extended-release, abuse-deterrent opioid succeeds in Ph3 trial
Drug Delivery Business News
Tue, 11/28/17 - 10:01 am
Egalet
abuse-resistant painkillers
clinical trials
opioids
Egalet-002
Is a Challenge to FDA’s “Route-of-Abuse” 3-Year Exclusivity Approach to Abuse-Deterrent Drug Products on the Horizon?
FDA Law Blog
Fri, 04/7/17 - 12:04 am
FDA
exclusivity
off-label
Egalet
Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO™ ER
Yahoo
Thu, 03/30/17 - 10:10 am
Egalet
opioids
painkillers
Arymo ER
Key FDA Decision And Trial Dates In February
Seeking Alpha
Mon, 01/30/17 - 11:03 pm
FDA
Amgen
Valeant Pharmaceuticals
Amphastar
Egalet
Lexicon Pharmaceuticals
Amicus Therapeutics
Axovant
The FDA Missed Egalet's PDUFA Date, But Investors Should Not Be Worried
Yahoo/Benzinga
Sat, 10/15/16 - 12:36 pm
FDA
Egalet
PDUFA
Arymo ER
Flex Pharma’s cramp study fails, shares plunge; FDA makes Egalet wait on pain drug
Endpoints
Fri, 10/14/16 - 11:52 am
Flex Pharma
FDA
Egalet
FLX-787
leg cramps
Arymo ER
opioids
Egalet's pain pill is tougher to abuse than Purdue's morphine tablet, study shows
Fierce Biotech
Thu, 07/2/15 - 11:24 am
Egalet
Purdue
abuse-resistant painkillers
Egalet-001
Tiny Egalet scouting for 60 reps to hawk its new pain meds
Fierce Pharma Marketing
Wed, 04/1/15 - 10:51 am
Egalet
hirings
Sprix
Egalet to hire up to 60 sales reps for launch of two pain medicines
Bizjournals.com
Wed, 03/25/15 - 09:42 am
hirings
Egalet
drug reps
Oxaydo
Sprix
IPO boom: 8 biotechs bag half a billion in a banner week
Fierce Biotech
Fri, 02/7/14 - 10:59 am
IPOs
Argos Therapeutics
Eleven Biotherapeutics
Revance Therapeutics
Egalet
uniQure
Auspex Pharmaceuticals
Genocea Biosciences
Biocept
Biotech startup Egalet lassos $14.3M B round, new CEO
Fierce Biotech
Thu, 05/10/12 - 11:09 am
Egalet